Global API footprints Vivimed Labs operates 12 manufacturing facilities with 4 US FDA approved sites and multiple overseas R&D centers, indicating a strong scale for contract manufacturing, API supply, and finished dosage formulations—a fertile ground for increased OEM/CMO collaborations and long-term supply partnerships.

Diversified portfolio Active ingredients and formulations span Home & Personal Care, Industrial care, and Healthcare segments with ambitions to expand into Printable Electronics and Organic Semiconductors, presenting cross-vertical selling opportunities for specialized chemistries, regulatory-compliant supply chains, and niche ingredient sourcing.

Global reach Established presence in nearly 50 countries with global support offices in India, China, Europe, and the USA, enabling scalable market entry strategies, regional sales acceleration, and turnkey support for multinational customers seeking consistent quality and compliance.

Growth through acquisitions History of strategic acquisitions such as UQUIFA and SONEAS signals a propensity for accelerated capability expansion, presenting opportunities to target customers seeking integrated supply chains, CDMO partnerships, and expanded formulation capabilities.

Quality and compliance emphasis US FDA approvals across multiple facilities and PIC/S GMP accreditation underscore a strong quality discipline, making Vivimed an attractive partner for risk-averse clients in regulated markets seeking reliable API, FDF, and finished formulation manufacturing.